Skip to main content
Premium Trial:

Request an Annual Quote

MDxHealth Inks Commercialization Deal for SelectMDx Prostate Cancer Test

NEW YORK (GenomeWeb) – MDxHealth announced today that it has signed an agreement to commercialize its SelectMDx prostate cancer test in France, Belgium, and Luxembourg through Cerba HealthCare Belgium.

Under the terms of the two-year deal, Cerba will offer the test through its laboratory network, initially analyzing patient samples at MDxHealth's service-testing lab in the Netherlands. Later, Cerba will begin testing samples at its own medical biology test lab in Belgium.

Additional terms were not disclosed.

SelectMDx is a urine-based assay designed to identify men at high risk for aggressive prostate cancer who may benefit from early detection and an initial prostate biopsy or MRI, as well as those at very low risk for this disease.

Earlier this year, MDxHealth signed an agreement giving the Andros Men's Health Clinic the rights to offer the test in the Netherlands

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.